Management Board

Bluepharma is led by a team of seasoned executives and entrepreneurs with broad experience in the pharmaceutical business.

Paulo Barradas Rebelo

Chairman

With an academic degree in Pharmaceutical Sciences and a Post-Graduate degree in Pharmaceutical Management, he has assumed various leadership roles in entities operating in the pharmaceutical area, namely in the National Pharmacies' Association and National Pharmaceutical College. Furthermore, he was also a Technical Director and owner of pharmacies established in central Portugal and Director of Farbeira – a distribution co-op.

In 2001, he led a group of professionals that launched Bluepharma, after acquiring the industrial facilities previously owned by the multinational company Bayer, in Coimbra. His role was instrumental in defining the strategic path that led to the company's turn-around performance.

Aside from managing other companies, he is currently the chairman and Executive President of Bluepharma and Bluepharma Genéricos. He is also a member of Luzitin´s and A2B's administrative board.

Ana Isabel Oliveira Rebelo

Vice-president

Degree in Pharmaceutical Sciences from the University of Coimbra.

She is Technical Director and Manager of Farmácia Estádio, in Coimbra, since June 2001. At the same time, she assumes functions in several companies as Managing Partner of IPBR Gest, SGPS, Lda, in Coimbra, since December 2010, Managing Partner of Torre de Palma, Lda and Manager of Óptica Estádio, Lda.

Currently, in addition to managing several companies, she is Vice President of Bluepharma.

Sérgio Simões

Vice-president

Areas of Interest/Expertise: Life sciences investment; Drug development (from discovery to regulatory); Pharmaceutical Business development; nanotechnology; Biotechnology.

Sérgio Simões has a degree in Pharmaceutical Sciences, a Master degree in Chemical Engineering and a Ph.D. in Pharmaceutical Sciences.

He has built a rapport as an entrepreneur, an investor and as a decision-making executive in the pharmaceutical industry. His role has been instrumental in the launch of several technology-based companies, including Bluepharma, Luzitin, Treat U and Blueclinical, as well as in the running of investment ventures such as a2b or Biocant Venture. He currently holds a position as Member of the Board of Bluepharma and Blueclinical, as well as a Professor at the Faculty of Pharmacy of the University of Coimbra – Portugal.

Apart from his research work on the development of novel nano-platforms for drug and nucleic acid delivery, he has gained a significant expertise on drug development, licensing and transfer of technology, and manufacturing of medicines for the European and US market. He has published more than 160 SCI journal papers, 10 book chapters and several patents.

Maria Isolina Mesquita

Vice-president

With a degree in German and English Philology and a Post-graduate degree in European Law and Economics, both granted by the University of Coimbra, she is highly experienced in industrial management.

Her career has from early on been linked to Bayer, where she undertook several and progressively larger responsibilities, which helped her acquire solid expertise in the different aspects of running an industry. Having joined the company as a trainee, she later received formal training for two years in the company's headquarters in Germany. In 1990 she assumed the duties of General Director of Bayer's industrial unit in Coimbra. In 2001, her role was instrumental in managing the the transition from Bayer to the current Bluepharma, having contributed towards bringing together the german knowledge and accuracy and the dynamism of the new managing team.

With Bluepharma's launch, she became Head of Operations and is currently its Vice-President.

Miguel Silvestre

Vice-president

Miguel Silvestre has a degree in Pharmaceutical Sciences by the University of Coimbra.

He is currently vice president of Bluepharma and administrator of Bluepharma Genéricos – Comércio de Medicamentos, S.A., an activity he carries out while also being the Chairman of the Board of Plural – Cooperativa Farmacêutica Crl. Currently, he is president of MONAF - Montepio Nacional da Farmácia - Associação de Socorros Mútuos and managing partner of Farmácia de Celas, in Coimbra. His extensive business experience is also noticeable in his involvement as a Board Member of A2B SGPS, S.A. and as a managing partner of MMS Investimentos SGPS Lda. and Salty, Lda. Since February 2016, he is president of the National Pharmaceutical Council of the Pharmacists Order.

Along with key positions held in companies that span over several sectors of activity, he was also an active member of the governing body of the National Association of Pharmacies, presiding over the Delegation of the Centre from 2000 to 2014.





Executive Comission

Bluepharma is led by a team of seasoned executives and entrepreneurs with broad experience in the pharmaceutical business.

Paulo Barradas Rebelo

Paulo Barradas Rebelo

Chief Executive Officer

Maria Isolina Mesquita

Ana Isabel Oliveira Rebelo

Vice-President

Sérgio Simões

Sérgio Simões

Vice-President

Maria Isolina Mesquita

Maria Isolina Mesquita

Vice-President

Miguel Silvestre

Miguel Silvestre

Vice-President



Governance Bodies

Bluepharma Indústria

Company's Registration

Bluepharma Indústria Farmacêutica, SA

Cimo de Fala – S. Martinho do Bispo, freguesia de S. Martinho do Bispo, concelho de Coimbra

Registered in Coimbra, Portugal under no. 8537

VAT: 505 282 801

Share capital: 4.550.000

General Assembly

Miguel Nuno Pereira Monteiro
PRESIDENT

Catarina Luís Farinha
SECRETARY

Management Board

Paulo Barradas Rebelo
CHAIRMAN

Ana Isabel Oliveira Rebelo
VICE-PRESIDENT

Sérgio Simões
VICE-PRESIDENT

Maria Isolina Mesquita
VICE-PRESIDENT

Statutory Auditor:

PricewaterhouseCoopers & Associados - Sociedade de Revisores Oficiais de Contas, Lda., here represented by:

Hugo Miguel Patrício Dias
Enrolled at the College of Auditors under no. 1432
EFFECTIVE AUDITOR